ISL
NTRP

Ingalls & Snyder LLC’s Neurotrope, Inc. Common NTRP Stock Holding History

Ingalls & Snyder LLC’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,000
Closed -$13K – 447
2019
Q3 		$13K Sell
16,000
-2,900
-15% -$13.3K ﹤0.01% 420
2019
Q2 		$152K Sell
18,900
-3,400
-15% -$22.9K 0.01% 408
2019
Q1 		$122K Sell
22,300
-100
-0.4% -$430 0.01% 400
2018
Q4 		$80K Sell
22,400
-24,400
-52% -$148K ﹤0.01% 396
2018
Q3 		$412K Buy
46,800
+13,100
+39% +$125K 0.02% 320
2018
Q2 		$326K Buy
+33,700
New +$310K 0.02% 324

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ingalls & Snyder LLC's NTRP Position: Q4 2019 in Review

Ingalls & Snyder LLC sold out of Neurotrope, Inc. Common (NTRP) in Q4 2019, closing a stake of 16,000 shares — an estimated $13K sold.

Ingalls & Snyder LLC first reported a position in NTRP in Q2 2018 and held it in 6 quarters. The position peaked at $412K in Q3 2018. 21 funds tracked by Wall St. Rank hold NTRP as of Q4 2019.

  • Ingalls & Snyder LLC reported no remaining Neurotrope, Inc. Common position as of Q4 2019 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 16,000 Neurotrope, Inc. Common shares in Q4 2019, an estimated $13K.
  • Ingalls & Snyder LLC first reported a position in Neurotrope, Inc. Common in Q2 2018 and held it in 6 quarters.
  • Ingalls & Snyder LLC's Neurotrope, Inc. Common position peaked at $412K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2019.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.